ArchiMed teams up with CDPQ to recap Corealis Pharma

ArchiMed has led the recapitalization of Corealis Pharma, a Laval, Quebec-based formulator and maker of solid dosage oral pharmaceuticals during pre-clinical and clinical pre-commercialization trials.

24 May 2022•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles